When did the new requirements for “specifically defined” nucleotides and amino acids come into effect?

According to MPEP 2412.03(a), the new requirements for “specifically defined” nucleotides and amino acids came into effect for patent applications filed on or after July 1, 2022. The MPEP states: [Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as…

Read More

When did the new requirements for nucleotide and amino acid sequence disclosures in patent applications take effect?

The new requirements for nucleotide and amino acid sequence disclosures in patent applications took effect on July 1, 2022. This is clearly stated in MPEP 2412.02(a): “[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR…

Read More

What is a DOCTYPE declaration in a Sequence Listing XML?

A DOCTYPE declaration in a Sequence Listing XML is a specific line of code that must be included in the XML file to comply with WIPO Standard ST.26. According to MPEP 2413.01(d), the DOCTYPE declaration should be: This declaration specifies the document type and version of the Sequence Listing XML, ensuring compatibility with WIPO standards.…

Read More

How are modified nucleotides described in a patent application?

Modified nucleotides in patent applications are described according to MPEP 2412.05(b) as follows: Represent modified nucleotides as the corresponding unmodified nucleotides (a, c, g, t) when possible Use the symbol “n” for modified nucleotides that cannot be represented by other symbols Further describe modified nucleotides in a feature table using the feature key “modified_base” Use…

Read More

How should regions of consecutive modified nucleotides be described in a patent application?

According to MPEP 2412.05(b), regions of consecutive modified nucleotides in patent applications should be described as follows: Describe the region in a feature table as required for a modified nucleotide Modified nucleotides in the region can be jointly described in a single INSDFeature element Provide the most restrictive unabbreviated chemical name or a list of…

Read More